Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Review

Research Support, Non-U.S. Gov't

Clinical Trial

Randomized Controlled Trial

Comparative Study

Controlled Clinical Trial

Research Support, U.S. Gov't, P.H.S.

Clinical Trial, Phase I

Multicenter Study

Publication Year

From

Quick links

Individual year

2018

2017

2015

2014

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Chlamydophila pneumoniae""[mesh_terms]

28 Results

Searching titles within these results

Chlamydophila pneumoniae.

F Blasi, P Tarsia, S Aliberti

Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2009;15(1):29-35

Free Full Text

Abstract

Role of Atypical Pathogens in the Etiology of Community-Acquired Pneumonia.

Forest W Arnold, James T Summersgill, Julio A Ramirez

Seminars in respiratory and critical care medicine 2018;37(6):819-828

Full Text

Abstract

Community-acquired pneumonia: role of atypical organisms.

R Cosentini, P Tarsia, F Blasi, E Roma, L Allegra

Monaldi archives for chest disease = Archivio Monaldi per le malattie del torace 2002;56(6):527-34

Full Text

Abstract

Impact of micro-environmental changes on respiratory tract infections with intracellular bacteria.

Kensuke Shima, Jonas Coopmeiners, Simon Graspeuntner, Klaus Dalhoff, Jan Rupp

FEBS letters 2017;590(21):3887-3904

Free Full Text

Abstract

Chlamydia pneumoniae and Mycoplasma pneumoniae.

Francesco Blasi, P Tarsia, S Aliberti, R Cosentini, L Allegra

Seminars in respiratory and critical care medicine 2006;26(6):617-24

Full Text

Abstract

Heparin-binding outer membrane protein of chlamydiae.

R S Stephens, A Kubo, E Lewis, K Koshiyama

Molecular microbiology 2001;40(3):691-9

Free Full Text

Abstract

Microbiological efficacy of ABT-773 (cethromycin) for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae.

Stanley Bukofzer, James Summersgill, Julio Ramirez, Patricia M Roblin, Tamara Reznik, Margaret R Hammerschlag

The Journal of antimicrobial chemotherapy 2003;51(4):1025-8

Full Text

Abstract

Can long-term antibiotic treatment prevent progression of peripheral arterial occlusive disease? A large, randomized, double-blinded, placebo-controlled trial.

J B Joensen, S Juul, E Henneberg, G Thomsen, L Ostergaard, J S Lindholt

Atherosclerosis 2008;196(2):937-42

Full Text

Abstract

Both hepatitis C virus and Chlamydia pneumoniae infection are related to the progression of carotid atherosclerosis in patients undergoing lipid lowering therapy.

Jun Hayashi, Norihiro Furusyo, Kyoko Okada, Shinji Maeda, Yasunori Sawayama, Hachiro Ohnishi

Fukuoka igaku zasshi = Hukuoka acta medica 2007;97(8):245-55

Free Full Text

Abstract

Development and assessment of antiatherosclerotic therapies beyond low-density lipoprotein cholesterol and blood pressure.

C M Ballantyne

Current atherosclerosis reports 2001;2(4):281-3

Full Text

Exploiting antigenic diversity for vaccine design: the chlamydia ArtJ paradigm.

Marco Soriani, Pierre Petit, Renata Grifantini, Roberto Petracca, Giovanni Gancitano, Elisabetta Frigimelica, Filomena Nardelli, Christel Garcia, Silvia Spinelli, Guido Scarabelli, Sebastien Fiorucci, Roman Affentranger, Mario Ferrer-Navarro, Martin Zacharias, Giorgio Colombo, Laurent Vuillard, Xavier Daura, Guido Grandi

The Journal of biological chemistry 2010;285(39):30126-38

Free Full Text

Abstract

The next step in cardiovascular protection.

Christopher P Cannon

Atherosclerosis. Supplements 2004;4(5):3-9

Full Text

Abstract

Antimicrobial effect of natural polyphenols with or without antibiotics on Chlamydia pneumoniae infection in vitro.

Caterina Romano Carratelli, Antonietta Rizzo, Antonio Losacco, Maria Rosaria Iovene

Microbial drug resistance (Larchmont, N.Y.) 2014;20(1):1-10

Full Text

Abstract

New and emerging theories of cardiovascular disease: infection and elevated iron.

Patricia T Alpert

Biological research for nursing 2004;6(1):3-10

Full Text

Abstract

Atypical pneumonia.

Marina Basarab, M Bruce Macrae, Carmel M Curtis

Current opinion in pulmonary medicine 2015;20(3):247-51

Full Text

Abstract

Results: 1 – 15 / 28

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Chlamydophila pneumoniae""[mesh_terms]

Chlamydophila pneumoniae.

Role of Atypical Pathogens in the Etiology of Community-Acquired Pneumonia.

Community-acquired pneumonia: role of atypical organisms.

Impact of micro-environmental changes on respiratory tract infections with intracellular bacteria.

Chlamydia pneumoniae and Mycoplasma pneumoniae.

Heparin-binding outer membrane protein of chlamydiae.

Microbiological efficacy of ABT-773 (cethromycin) for the treatment of community-acquired pneumonia due to Chlamydia pneumoniae.

Can long-term antibiotic treatment prevent progression of peripheral arterial occlusive disease? A large, randomized, double-blinded, placebo-controlled trial.

Both hepatitis C virus and Chlamydia pneumoniae infection are related to the progression of carotid atherosclerosis in patients undergoing lipid lowering therapy.

Development and assessment of antiatherosclerotic therapies beyond low-density lipoprotein cholesterol and blood pressure.

Exploiting antigenic diversity for vaccine design: the chlamydia ArtJ paradigm.

The next step in cardiovascular protection.

Antimicrobial effect of natural polyphenols with or without antibiotics on Chlamydia pneumoniae infection in vitro.

New and emerging theories of cardiovascular disease: infection and elevated iron.

Atypical pneumonia.

Results for
""Chlamydophila pneumoniae""[mesh_terms]